Open Access

Reversal of brain aging by targeting telomerase: A nutraceutical approach

  • Authors:
    • Dimitris Tsoukalas
    • Ana Maria Buga
    • Anca Oana Docea
    • Evangelia Sarandi
    • Radu Mitrut
    • Elisavet Renieri
    • Demetrios A. Spandidos
    • Ion Rogoveanu
    • Liliana Cercelaru
    • Mihaela Niculescu
    • Aristidis Tsatsakis
    • Daniela Calina
  • View Affiliations

  • Published online on: September 10, 2021     https://doi.org/10.3892/ijmm.2021.5032
  • Article Number: 199
  • Copyright: © Tsoukalas et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Telomeres, the protective caps of chromosomes, shorten with age, as telomerase, the enzyme responsible for the compensation of telomere erosion, is inactive in the majority of cells. Telomere shortening and subsequent cell senescence lead to tissue aging and age‑related diseases. Neurodegenerative disorders, characterized by the progressive loss of neurons among other hallmarks of aged tissue, and poor cognitive function, have been associated with a short telomere length. Thus, telomerase activity has emerged as a therapeutic target, with novel agents being under investigation. The present study aimed to examine the effects of a novel natural telomerase activator, ‘Reverse™’, containing Centella asiatica extract, vitamin C, zinc and vitamin D3 on the brains of 18‑month‑old rats. The administration of the ‘Reverse™’ supplement for 3 months restored telomerase reverse transcriptase (TERT) expression in the brains of rats, as revealed by ELISA and immunohistochemistry. In addition, the findings from PCR‑ELISA demonstrated an enhanced telomerase activity in the cerebellum and cortex cells in the brains of rats treated with the ‘Reverse™’ supplement. The histopathological findings confirmed a structural reversibility effect close to the differentiation observed in the young control group of rats treated with two capsules/kg body weight of the ‘Reverse™’ supplement. On the whole, the findings of the present study provide a strong indication that an increased telomerase activity and TERT expression may be achieved not only in the postnatal or embryonic period, but also in the brains of middle‑aged rats through nutraceutical supplementation. The use of the ‘Reverse™’ supplement may thus contribute to the potential alleviation of a number of central nervous system diseases.
View Figures
View References

Related Articles

Journal Cover

November-2021
Volume 48 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tsoukalas D, Buga AM, Docea AO, Sarandi E, Mitrut R, Renieri E, Spandidos DA, Rogoveanu I, Cercelaru L, Niculescu M, Niculescu M, et al: Reversal of brain aging by targeting telomerase: A nutraceutical approach. Int J Mol Med 48: 199, 2021
APA
Tsoukalas, D., Buga, A.M., Docea, A.O., Sarandi, E., Mitrut, R., Renieri, E. ... Calina, D. (2021). Reversal of brain aging by targeting telomerase: A nutraceutical approach. International Journal of Molecular Medicine, 48, 199. https://doi.org/10.3892/ijmm.2021.5032
MLA
Tsoukalas, D., Buga, A. M., Docea, A. O., Sarandi, E., Mitrut, R., Renieri, E., Spandidos, D. A., Rogoveanu, I., Cercelaru, L., Niculescu, M., Tsatsakis, A., Calina, D."Reversal of brain aging by targeting telomerase: A nutraceutical approach". International Journal of Molecular Medicine 48.5 (2021): 199.
Chicago
Tsoukalas, D., Buga, A. M., Docea, A. O., Sarandi, E., Mitrut, R., Renieri, E., Spandidos, D. A., Rogoveanu, I., Cercelaru, L., Niculescu, M., Tsatsakis, A., Calina, D."Reversal of brain aging by targeting telomerase: A nutraceutical approach". International Journal of Molecular Medicine 48, no. 5 (2021): 199. https://doi.org/10.3892/ijmm.2021.5032